Screening for Hypertension in Adults

Guirguis-Blake, Janelle; Evans, Corinne V; Webber, Elizabeth M.; Coppola, Erin L.; Perdue, Leslie A; Weyrich, Meghan S

doi:10.1001/jama.2020.21669

Cited by 77 publications

(9 citation statements)

References 125 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In the context of the former two, factors such as gender, age, lifestyle, and comorbidities emerged as influential. These findings align with international studies, where risk factors for prehypertension and HBP often overlap with those for HTN (31,32) .…”

Section: Factors Associated With Prehypertension and Hbpsupporting

confidence: 88%

Analysis of Hypertension in Peru: Prevalence, Associated Factors, Knowledge, Management and Control, 2014-2022

Vera-Ponce,

Zuzunaga-Montoya,

Vásquez-Romero

et al. 2024

Preprint

View full text Add to dashboard Cite

Introduction: Hypertension (HTN), prehypertension, and High Blood Pressure (HBP) represent a chronic medical condition of growing global concern. Highlighting the importance of Awareness, medication, and Control of HTN is essential. A significant proportion of hypertensive patients are unaware of their condition, hindering proper and early treatment. Among those diagnosed, not all receive or follow pharmacological treatment, and an even smaller percentage achieves effective blood pressure control. Objective: The main objectives include determining the prevalence, trends, and associated factors of HTN, as well as investigating prehypertension and the variability in HBP levels during the same period. Special attention will be given to self-reported, medicated, and Controlled hypertension, analyzing its evolution and associated factors. Methods: We conducted an analytical cross-sectional study using the National Survey of Demographic and Family Health database between 2014 and 2022. Our study included individuals aged 18 years and older, as the definitions of HTN apply to people from this age onwards. Results: The study revealed an overall HTN, prehypertension, and HBP prevalence of 20.76%, 33.44%, and 33.44%, respectively, with annual variations. An increasing trend in the prevalence of known, medicated, and controlled HTN was observed, with factors such as gender, age, educational level, and geographical region significantly influencing it. Conclusions: The investigation into HTN in Peru revealed an expanding occurrence of HTN, prehypertension, and HBP, emphasizing the necessity for early identification, suitable treatment, and effective management of HTN. A significant gap is observed between the condition's awareness and effective management, highlighting the urgent need for public health strategies that address both the prevention and treatment of HTN in Peru.

show abstract

Section: Factors Associated With Prehypertension and Hbpsupporting

confidence: 88%

Analysis of Hypertension in Peru: Prevalence, Associated Factors, Knowledge, Management and Control, 2014-2022

Vera-Ponce,

Zuzunaga-Montoya,

Vásquez-Romero

et al. 2024

Preprint

View full text Add to dashboard Cite

show abstract

“…10 , 13 In comparison, basic screening for hypertension, dyslipidemia, and diabetes was more prevalent, perhaps reflective of the frequency of routine screening for these conditions in the general adult population without a cancer history. 26 , 27 We observed low rates of SCP utilization, consistent with participants who were diagnosed before SCPs were recommended and received much of their survivorship care in an era generally marked by slow adoption among PCPs. 28 Factors associated with having up-to-date cardiovascular disease screening included documentation in the medical record of a participant having an increased risk for cardiovascular disease and a need for late-effects surveillance.…”

Section: Discussionsupporting

confidence: 59%

Primary Care Utilization and Cardiovascular Screening in Adult Survivors of Childhood Cancer

Ohlsen,

Chen,

Baldwin

et al. 2023

JAMA Netw Open

View full text Add to dashboard Cite

ImportanceCardiovascular disease is the leading noncancer cause of premature death among survivors of childhood cancer. Adult survivors of childhood cancer are largely managed by primary care practitioners (PCPs), and health care utilization patterns related to cardiovascular screening are not well described.ObjectiveTo examine screening and health care utilization among survivors of childhood cancer at high risk for cardiovascular complications.Design, Setting, and ParticipantsThis multicenter cross-sectional study included participants enrolled in a randomized clinical trial from 2017 to 2021. Abstracted documentation of participants’ cancer history, cardiotoxic treatment exposures, and survivorship care plans were obtained from participants’ PCPs spanning 2 years preceding trial enrollment. Participants were members of the Childhood Cancer Survivor Study cohort at elevated risk for ischemic heart disease or heart failure, enrolled in a randomized trial focused on improving cardiovascular risk factor control. Data were analyzed from November 2022 to July 2023.Main Outcomes and MeasuresOutcomes of interest were numbers of PCP and specialist visits, cardiovascular risk factors (hypertension, dyslipidemia, and diabetes), risk factor screening, and cardiac testing. Multivariable logistic regression assessed characteristics associated with up-to-date cardiac testing at enrollment.ResultsOf 347 enrolled participants, 293 (84.4%) had evaluable medical records (median [range] age, 39.9 [21.5-65.0] years; 149 [50.9%] male) and were included in analyses. At baseline, 238 participants (81.2%) had a documented PCP encounter; 241 participants (82.3%) had undergone blood pressure screening, 179 participants (61.1%) had undergone lipid testing, and 193 participants (65.9%) had undergone diabetes screening. A total of 63 participants (21.5%) had echocardiography completed or planned. Only 198 participants (67.6%) had records referencing a cancer history. PCP documentation of prior cardiotoxic exposures was low compared with known exposures, including radiation therapy (103 participants [35.2%] vs 203 participants [69.3%]; P &lt; .001) and anthracycline chemotherapy (27 participants [9.2%] vs 222 participants [75.8%]; P = .008). Few records referenced a need for cancer-related late effects surveillance (95 records [32.4%]). Independent factors associated with cardiac screening included documentation of increased cardiovascular disease risk (odds ratio [OR], 11.94; 95% CI, 3.37-42.31), a late-effects surveillance plan (OR, 3.92; 95% CI, 1.69-9.11), and existing cardiovascular risk factors (OR per each additional factor, 2.09; 95% CI, 1.32-3.31).Conclusions and RelevanceThis cross-sectional study of adult survivors of childhood cancer at increased risk of cardiovascular disease found low adherence to recommended cardiac testing and documentation of risk for these individuals. Improving accuracy of reporting of survivors’ exposures and risks within the medical record may improve screening.

show abstract

“…It is a substantial factor for the development of atherosclerosis, with a high global incidence and prevalence that continues to increase and contributes to worldwide morbidity and mortality [1]. It constitutes a major risk factor for MetS-related cardiovascular disease and the leading cause of mortality related with MetS-associated chronic kidney failure, ischemic heart disease and stroke [2,3]. In 2015, a total of 1.13 billion adults had arterial hypertension worldwide [4]; this figure is predicted to increase to 1.56 billion by 2025 [5].…”

Section: Introductionmentioning

confidence: 99%

Impact of Helicobacter pylori-Related Metabolic Syndrome Parameters on Arterial Hypertension

et al. 2021

View full text Add to dashboard Cite

Arterial hypertension is a risk factor for several pathologies, mainly including cardio-cerebrovascular diseases, which rank as leading causes of morbidity and mortality worldwide. Arterial hypertension also constitutes a fundamental component of the metabolic syndrome. Helicobacter pylori infection is one of the most common types of chronic infection globally and displays a plethora of both gastric and extragastric effects. Among other entities, Helicobacter pylori has been implicated in the pathogenesis of the metabolic syndrome. Within this review, we illustrate the current state-of-the-art evidence, which may link several components of the Helicobacter pylori-related metabolic syndrome, including non-alcoholic fatty liver disease and arterial hypertension. In particular, current knowledge of how Helicobacter pylori exerts its virulence through dietary, inflammatory and metabolic pathways will be discussed. Although there is still no causative link between these entities, the emerging evidence from both basic and clinical research supports the proposal that several components of the Helicobacter pylori infection-related metabolic syndrome present an important risk factor in the development of arterial hypertension. The triad of Helicobacter pylori infection, the metabolic syndrome, and hypertension represents a crucial worldwide health problem on a pandemic scale with high morbidity and mortality, like COVID-19, thereby requiring awareness and appropriate management on a global scale.

show abstract

Screening for Hypertension in Adults

Cited by 77 publications

References 125 publications

Analysis of Hypertension in Peru: Prevalence, Associated Factors, Knowledge, Management and Control, 2014-2022

Analysis of Hypertension in Peru: Prevalence, Associated Factors, Knowledge, Management and Control, 2014-2022

Primary Care Utilization and Cardiovascular Screening in Adult Survivors of Childhood Cancer

Impact of Helicobacter pylori-Related Metabolic Syndrome Parameters on Arterial Hypertension

Contact Info

Product

Resources

About